Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Operating Grant - PA: HIV/AIDS Bridge Funding - Biomedical/Clinical Stream

University of Calgary

$100,000.00

Pathology of Occult Hepatitis B Virus (HBV) Infection in HIV-1 Coinfected Patients

FY 2008-09

Summary
Human Immunodeficiency virus type 1 (HIV-1) and hepatitis B virus (HBV) are both transmitted through contact with infected blood and body fluids, thus coinfection with both viruses is common. HBV can cause serious liver disease such as cirrhosis (i.e., scarring of the liver) and liver cancer, and the rate of liver disease is often accelerated in coinfected persons. Occult HBV infection is a relatively newly recognized category of chronic HBV infection that is characterized by low levels of HBV detectable only by sensitive molecular tests. Our clinic cares for approximately 2700 persons living with HIV and has collected sequential blood samples over a 15 year period. We aim to study these persons for evidence of occult HBV infection and if so, determine whether it has affected their clinical outcome. We will analyze the genetic sequence of each virus to determine whether coinfection can affect the development of resistance to both HBV and HIV antiviral drug therapy. Finally we will study how viruses can interact with each other during coinfection and affect each others replication status. The aims of this study are to (1) recognize the prevalence of occult HBV infection in persons living with HIV (2) recognize whether these persons are at risk for progressive liver disease and/or progressive HIV disease (3) determine the effect of co-infection on development of drug resistance and, (4) help understand the mechanisms of how virues can affect each other during co-infection. This is the first comprehensive study assessing the health implications of occult HBV and HIV co-infection.
Program
Operating Grant - PA: HIV/AIDS Bridge Funding - Biomedical/Clinical Stream
Location
Alberta, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
186812
Name
Coffin Carla S
Region
Alberta
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Infection and Immunity
Theme2
Clinical
Prcname2
Virology & Viral Pathogenesis
Projecttitle
Pathology of Occult Hepatitis B Virus (HBV) Infection in HIV-1 Coinfected Patients
Programtype2
Operating Grants
Orgnameinp2
University of Calgary
Cihramount2
$100,000
Cihrequipment2
$0
Programname2
Operating Grant - PA: HIV/AIDS Bridge Funding - Biomedical/Clinical Stream
Keyworddelim
Dna Sequencing; Hiv Coinfection And Liver Disease; Lymphoid Cell Culture; Mitogen Stimulation; Nested Pcr/Nucleic Acid Hybridization; Occult Hepatitis B Virus; Quantitiative Pcr; Viral Lymphotropism
Abstract
Human Immunodeficiency virus type 1 (HIV-1) and hepatitis B virus (HBV) are both transmitted through contact with infected blood and body fluids, thus coinfection with both viruses is common. HBV can cause serious liver disease such as cirrhosis (i.e., scarring of the liver) and liver cancer, and the rate of liver disease is often accelerated in coinfected persons. Occult HBV infection is a relatively newly recognized category of chronic HBV infection that is characterized by low levels of HBV detectable only by sensitive molecular tests. Our clinic cares for approximately 2700 persons living with HIV and has collected sequential blood samples over a 15 year period. We aim to study these persons for evidence of occult HBV infection and if so, determine whether it has affected their clinical outcome. We will analyze the genetic sequence of each virus to determine whether coinfection can affect the development of resistance to both HBV and HIV antiviral drug therapy. Finally we will study how viruses can interact with each other during coinfection and affect each others replication status. The aims of this study are to (1) recognize the prevalence of occult HBV infection in persons living with HIV (2) recognize whether these persons are at risk for progressive liver disease and/or progressive HIV disease (3) determine the effect of co-infection on development of drug resistance and, (4) help understand the mechanisms of how virues can affect each other during co-infection. This is the first comprehensive study assessing the health implications of occult HBV and HIV co-infection.
Competitiondate
200903
Approvedterm2
1 yr 0 mth
Pinamesdelim
Coffin, Carla S
Approvedterm
1 an 0 mois
Cihrcontribution2
Science Policy 4~ $100,000~ $0~
University of Calgary - $100,000 Grant (2008-09) | Canada Spends